Skip to content
Author Guidelines
Permissions
About JCAD
Advertise
Contact
Menu
Author Guidelines
Permissions
About JCAD
Advertise
Contact
Home
Subscribe
Archive
Supplements
NP+PA Perspectives
Online Exclusives
CME Activities
Home
Subscribe
Archive
Supplements
NP+PA Perspectives
Online Exclusives
CME Activities
Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data Digital Edition
October 1, 2022
Click the cover below to view the digital edition for this October 2022 JCAD supplement.
Facebook
Twitter
LinkedIn
Prev
Previous
Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data
Next
Effective Treatment of Inflammatory Lesions of Rosacea with Subantibiotic Dose Doxycycline Irrespective of Patient Weight or Baseline Lesion Count Severity
Next